Lv0
0 积分 2025-02-23 加入
Neoadjuvant treatment with disitamab vedotin plus perioperative toripalimab in patients with muscle-invasive bladder cancer (MIBC) with HER2 expression: Updated efficacy and safety results from the phase II RC48-C017 trial
8个月前
已完结
Disitamab vedotin plus toripalimab in patients with locally advanced or metastatic urothelial carcinoma (RC48-C014): a phase 1b/2 dose-escalation and dose-expansion study
8个月前
已完结
Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer
8个月前
已完结
Current Disease Management of Primary Urethral Carcinoma
8个月前
已完结
[Applications of Naked-Eye 3D Display Technology in Medical Field]
10个月前
已完结
皖公网安备34019202002308
